Quantitative stock rating · as of 2026-11-05

Krystal Biotech, Inc. (KRYS)

Name: Krystal Biotech, Inc. (KRYS) Stock Rating: B (Strong)
Item: Krystal Biotech, Inc.
Rating: B
Author: QuantHarbor

Strong

QuantHarbor five-lens rating band

Standout lens: Quality.
Main drag: Price Stability.

Price at the rating date (2026-11-05): $310.84.

The rating grades KRYS through five lenses — Quality, Valuation, Momentum, Growth Trend and Price Stability — computed from filings and market data, refreshed nightly. When data is too thin to score a lens, we withhold it instead of guessing.

See the full KRYS teardown free

Lens scores, the valuation zone, financial statement charts and the complete methodology are available with a free account. QuantHarbor is descriptive research, not investment advice.